Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hdac3 regulates lymphovenous and lymphatic valve formation
Harish P. Janardhan, … , John F. Keaney Jr., Chinmay M. Trivedi
Harish P. Janardhan, … , John F. Keaney Jr., Chinmay M. Trivedi
Published October 16, 2017
Citation Information: J Clin Invest. 2017;127(11):4193-4206. https://doi.org/10.1172/JCI92852.
View: Text | PDF
Research Article Development Vascular biology

Hdac3 regulates lymphovenous and lymphatic valve formation

  • Text
  • PDF
Abstract

Lymphedema, the most common lymphatic anomaly, involves defective lymphatic valve development; yet the epigenetic modifiers underlying lymphatic valve morphogenesis remain elusive. Here, we showed that during mouse development, the histone-modifying enzyme histone deacetylase 3 (Hdac3) regulates the formation of both lymphovenous valves, which maintain the separation of the blood and lymphatic vascular systems, and the lymphatic valves. Endothelium-specific ablation of Hdac3 in mice led to blood-filled lymphatic vessels, edema, defective lymphovenous valve morphogenesis, improper lymphatic drainage, defective lymphatic valve maturation, and complete lethality. Hdac3-deficient lymphovenous valves and lymphatic vessels exhibited reduced expression of the transcription factor Gata2 and its target genes. In response to oscillatory shear stress, the transcription factors Tal1, Gata2, and Ets1/2 physically interacted with and recruited Hdac3 to the evolutionarily conserved E-box–GATA–ETS composite element of a Gata2 intragenic enhancer. In turn, Hdac3 recruited histone acetyltransferase Ep300 to form an enhanceosome complex that promoted Gata2 expression. Together, these results identify Hdac3 as a key epigenetic modifier that maintains blood-lymph separation and integrates both extrinsic forces and intrinsic cues to regulate lymphatic valve development.

Authors

Harish P. Janardhan, Zachary J. Milstone, Masahiro Shin, Nathan D. Lawson, John F. Keaney Jr., Chinmay M. Trivedi

×

Figure 4

Hdac3 regulates Gata2 and its target gene expression in developing lymphatic valves and lymphovenous valves.

Options: View larger image (or click on image) Download as PowerPoint
Hdac3 regulates Gata2 and its target gene expression in developing lymph...
(A) Transcripts for Gata2, Foxc2, Gja4, and Itga9 were detected by ChIP-qPCR in control and Hdac3Cdh5KO mesenteric lymphatic vessels dissected from P5 mice. (B) Whole-mount immunofluorescence staining of Hdac3Cdh5KO mesenteric lymphatic vessels identified reduced Prox1 (red) expression in Vegfr3+ (red) LECs (red arrows) compared with controls (white arrows). (C) Transcripts for Gata2 and Foxc2 were detected by ChIP-qPCR in control and Hdac3Lyve1KO mesenteric lymphatic vessels dissected from P0 mice. (D) Transcripts for Gata2, Foxc2, Gja4, and Itga9 were detected by ChIP-qPCR in laser-captured control and Hdac3TekKO lymphovenous valves from E13.5 embryos. (E–G) Immunostaining of E13.5 Hdac3TekKO lymphovenous valves revealed reduced Gata2 (E, red arrows), Foxc2 (F, red arrows), and Prox1 (G, red arrows) expression compared with controls (black arrows). LV, lymphatic valve; R, rib. Data represent the mean ± SEM and are representative of 3 independent experiments. P values were determined by Student’s t test. Scale bars: 500 μm. See also Supplemental Figure 7.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts